The Epileptogenic Effect of Perinatal Hypoxia
The Epileptogenic Effect of Perinatal Hypoxia
批准号:
7432381
负责人:
Frances E Jensen
金额:
$42.25万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2008-05-31
关键词:
AcuteAdultAgeAnimalsAnoxic EncephalopathyAntiepileptic AgentsAutopsyBiological ModelsBrainBumetanideButyric AcidButyric AcidsCellsDevelopmentDiseaseEpilepsyEpileptogenesisExcitatory Amino Acid AntagonistsFundingGlutamate ReceptorGlutamatesGoalsGrantHippocampus (Brain)HumanHypoxiaImmunoblottingImpaired cognitionIn VitroInfantInterventionIsoxazolesLifeLong-Term PotentiationMessenger RNAMethodsModelingMolecular TargetMutant Strains MiceNeonatalNeuronsNeurotransmitter ReceptorNewborn InfantPathway interactionsPatternPerinatal HypoxiaPharmaceutical PreparationsPharmacotherapyPhosphorylationPhysiologicalPlayPost-Translational Protein ProcessingPredispositionPreventionProtein OverexpressionProteinsProto-Oncogene Proteins c-aktRattusRefractoryResearchRodentRodent ModelRoleSeizuresSignal PathwaySirolimusSiteStimulusSynaptic plasticityTestingTherapy Clinical TrialsTimeTissue BanksTissuesTranslationsage relatedbasebrain tissuecase controlconceptgenetic regulatory proteinhippocampal pyramidal neuronhuman tissueimmunocytochemistryin vivoinhibitor/antagonistneonatal humanneonatal hypoxic-ischemic brain injuryneuronal excitabilitypatch clamppreventprogramsprotein S precursorprotein expressionreceptorreceptor expressionreceptor functionresearch studysynaptogenesistherapeutic targettopiramate
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neonatal seizures associated with hypoxic encephalopathy are refractory to conventional AED therapy, and
are associated with long term neurodevelopmental delay, cognitive impairment and epilepsy. The newborn
brain is fundamentally different from the adult brain, and is uniquely susceptible to epileptic stimuli as a
function of physiological hyperexcitability required for activity dependent synaptogenesis and cortical
development. In the prior 15 years, this research program has generated a reliable rodent model of neonatal
hypoxic seizures, identified specific age-dependent mechanisms, validated the age specific expression of
these targets in human neonatal cortical tissue, and executed therapeutic trials in the rat targeted towards
these mechanisms, using clinically available drugs. In our rodent models of neonatal seizures, we have
shown that systemic administration of glutamate receptor antagonists for 48 hrs following seizures can
prevent the long term consequences, and hence may be disease modifying. The present proposal will focus
on this immediate and early post seizure window to identify rapid post-translational modifications of existing
protein and regulatory mechanisms governing the translation of protein from of pre-existing mRNA that may
be preventable and/or reversible.
Aim 1. To determine the time course of seizure-induced changes in ionotropic glutamate receptor function,
and whether they are associated with post-translational modification of receptor subunits.
Aim 2. To establish whether post-translational modifications in AMPARs and NMDARs are merely correlated
or mechanistically related to in hypoxic seizure-induced epileptogenesis in vivo and in vitro.
Aiim 3. To determine whether the mammalian target of rapamycin (mTOR) signaling pathway represents a
therapeutic target for prevention of hypoxic-seizure induced hyperexcitability.
Aim 4. To continue our human tissue study of maturational patterns of glutamate receptor expression and
investigate whether mTOR pathway activation can be detected in postmortem human brain tissue from
hypoxic term infants.
Our preliminary results reveal that many of these early seizure induced changes in proteins are strikingly
similar to those observed in models of synaptic plasticity. The overall hypothesis of this proposal is that
these early changes represent intervention points for antiepileptogenesis, even after the seizures have been
induced. A major focus for this funding period is to identify these molecular targets in this 48 hr window and
intervene with available off-the-shelf drugs that are known to have modulatory activity at these targets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease
-
批准号:10611518
-
项目类别:
-
资助金额:$72.06万
-
财政年份:2022
-
负责人:Frances E Jensen
-
依托单位:
Seizure-induced enhancement of synaptic signaling regulating tau transmissibility in Alzheimer's Disease
-
批准号:10455852
-
项目类别:
-
资助金额:$67.4万
-
财政年份:2022
-
负责人:Frances E Jensen
-
依托单位:
The NKCC1 inhibitor bumetanide as a novel therapy in TSC
-
批准号:8457417
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2012
-
负责人:Frances E Jensen
-
依托单位:
The NKCC1 inhibitor bumetanide as a novel therapy in TSC
-
批准号:8554384
-
项目类别:
-
资助金额:$18.79万
-
财政年份:2012
-
负责人:Frances E Jensen
-
依托单位:
Attenuating the retinal and CNS adverse effects of vigabatrin with NKCC1 inhibito
-
批准号:7937917
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2009
-
负责人:Frances E Jensen
-
依托单位:
Attenuating the retinal and CNS adverse effects of vigabatrin with NKCC1 inhibito
-
批准号:7829070
-
项目类别:
-
资助金额:$40.88万
-
财政年份:2009
-
负责人:Frances E Jensen
-
依托单位:
Understanding the Cognitive Impact of Early Life Epilepsy
-
批准号:7341202
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2007
-
负责人:Frances E Jensen
-
依托单位:
Understanding the Cognitive Impact of Early Life Epilepsy
-
批准号:8650480
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2007
-
负责人:Frances E Jensen
-
依托单位:
Understanding the Cognitive Impact of Early Life Epilepsy
-
批准号:8119615
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2007
-
负责人:Frances E Jensen
-
依托单位:
Understanding the Cognitive Impact of Early Life Epilepsy
-
批准号:7914219
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2007
-
负责人:Frances E Jensen
-
依托单位:
Understanding the Cognitive Impact of Early Life Epilepsy
-
批准号:7681264
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2007
-
负责人:Frances E Jensen
-
依托单位:
Mechanisms of Excitotoxic Injury to Oligodendrocytes
-
批准号:7006505
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2005
-
负责人:Frances E Jensen
-
依托单位:
Excitotoxic injury to developing oligodendrocytes
-
批准号:6565276
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2001
-
负责人:Frances E Jensen
-
依托单位:
Excitotoxic injury to developing oligodendrocytes
-
批准号:6410672
-
项目类别:
-
资助金额:$19.61万
-
财政年份:2000
-
负责人:Frances E Jensen
-
依托单位:
Excitotoxic injury to developing oligodendrocytes
-
批准号:6332566
-
项目类别:
-
资助金额:$19.61万
-
财政年份:1999
-
负责人:Frances E Jensen
-
依托单位:
Excitotoxic injury to developing oligodendrocytes
-
批准号:6330940
-
项目类别:
-
资助金额:$19.61万
-
财政年份:1999
-
负责人:Frances E Jensen
-
依托单位:
PERINATAL HYPOXIA/ISCHEMIA MODEL OF MR AND EPILEPSY
-
批准号:3478697
-
项目类别:
-
资助金额:$11.7万
-
财政年份:1992
-
负责人:Frances E Jensen
-
依托单位:
The Epileptogenic Effect of Perinatal Hypoxia
-
批准号:8739994
-
项目类别:
-
资助金额:$48.47万
-
财政年份:1992
-
负责人:Frances E Jensen
-
依托单位:
The Epileptogenic Effect of Perinatal Hypoxia
-
批准号:7869480
-
项目类别:
-
资助金额:$11.17万
-
财政年份:1992
-
负责人:Frances E Jensen
-
依托单位:
The Epileptogenic Effect of Perinatal Hypoxia
-
批准号:7612000
-
项目类别:
-
资助金额:$36.97万
-
财政年份:1992
-
负责人:Frances E Jensen
-
依托单位:
海外基金